Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 InfectionArticle Published on 2022-10-012023-07-07 Journal: The Annals of Pharmacotherapy [Category] [DOI] 10.1177/10600280211069182 PMC 바로가기
Inhaled pulmonary vasodilators are not associated with improved gas exchange in mechanically ventilated patients with COVID-19: A retrospective cohort studyObservational Study Published on 2022-06-012022-10-05 Journal: Journal of critical care [Category] [DOI] 10.1016/j.jcrc.2022.153990 PMC 바로가기 [Article Type] Observational Study
Evaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019Article Published on 2022-04-012023-07-08 Journal: Hospital practice (1995) [Category] [DOI] 10.1080/21548331.2022.2047310 PMC 바로가기
Pulmonary artery targeted therapy in treatment of COVID-19 related ARDS. Literature reviewReview article Published on 2022-02-012022-10-05 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] [DOI] 10.1016/j.biopha.2021.112592 [Article Type] Review article
Data mining methodology for response to hypertension symptomology—application to COVID-19-related pharmacovigilance고혈압 증상에 대한 데이터 마이닝 방법론 - COVID-19 관련 약물 감시에 적용Research Article Published on 2021-11-232022-09-10 Journal: eLife [Category] [DOI] 10.7554/eLife.70734 PMC 바로가기 [Article Type] Research Article
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationaleCommentary Published on 2021-09-162022-10-31 Journal: The Egyptian Heart Journal [Category] [DOI] 10.1186/s43044-021-00208-y PMC 바로가기 [Article Type] Commentary
Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19Observational Study Published on 2020-11-252022-10-04 Journal: Journal of Intensive Care Medicine [Category] [DOI] 10.1177/0885066620976525 PMC 바로가기 [Article Type] Observational Study